Publications:

PI3K/AKT/mTOR Pathway Alterations Promote Malignant Progression and Xenograft Formation in Oligodendroglial Tumors.

Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research

Tateishi, Kensuke K; Nakamura, Taishi T; Juratli, Tareq A TA; Williams, Erik A EA; Matsushita, Yuko Y; Miyake, Shigeta S; Nishi, Mayuko M; Miller, Julie J JJ; Tummala, Shilpa S SS; Fink, Alexandria L AL; Lelic, Nina N; Koerner, Mara V A MVA; Miyake, Yohei Y; Sasame, Jo J; Fujimoto, Kenji K; Tanaka, Takahiro T; Minamimoto, Ryogo R; Matsunaga, Shigeo S; Mukaihara, Shigeo S; Shuto, Takashi T; Taguchi, Hiroki H; Udaka, Naoko N; Murata, Hidetoshi H; Ryo, Akihide A; Yamanaka, Shoji S; Curry, William T WT; Dias-Santagata, Dora D; Yamamoto, Tetsuya T; Ichimura, Koichi K; Batchelor, Tracy T TT; Chi, Andrew S AS; Iafrate, A John AJ; Wakimoto, Hiroaki H; Cahill, Daniel P DP

Publication Date: 2019-07-15

Variant appearance in text: PIK3CA: E469G

PubMed Link: 30975663

Variant Present in the following documents:

• Main text

View BVdb publication page

Insights into the oncogenic effects of PIK3CA mutations from the structure of p110alpha/p85alpha.

Cell Cycle (Georgetown, Tex.)

Huang, Chuan-Hsiang CH; Mandelker, Diana D; Gabelli, Sandra B SB; Amzel, L Mario LM

Publication Date: 2008-05-01

Variant appearance in text: PI3K: Glu469Gly

PubMed Link: 18418043

Variant Present in the following documents:

• Main text

View BVdb publication page